Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to ...

Market multiples for Novo Nordisk are also attractive now, especially with a forward P/E for 2025 at 28.3x. Learn more about NVO stock here.

Years of layoffs and alleged mismanagement have left employees “sick” of the pharmaceutical contract manufacturer Catalent, ...

Eli Lilly said Wednesday that its obesity drug Zepbound spurred more weight loss than Novo Nordisk's Wegovy in a head-to-head clinical trial.

picture alliance / Contributor / Getty Images Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' weight-loss drugs in ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other profitable European stocks. After the U.S. Presidential elections, the global economies ...

Yet more adverts have been spotted in Windows 11 Ads for Black Ops 6 and Microsoft 365 appear via the notifications panel You can turn off these 'suggestions' though If you don’t like adverts in ...

Novo Nordisk, the maker of weight-loss drugs Ozempic and Wegovy, is suing at least five Chicago-area medical spas and health clinics, alleging they each are using false advertising and deceptive ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions online, despite a lack of evidence that they work. Now, though, on ...

Novo Nordisk continues to witness strong growth across its portfolio of diabetes and obesity care medications. The company's tailwinds include expanded indications and new geographic markets.

Jaguar has left people scratching their heads with a new glossy advert which fails to show any cars. The British luxury vehicle maker has released a commercial featuring a series of models ...

Over the last couple of years, Danish company Novo Nordisk (NYSE: NVO) has evolved from a relatively obscure pharmaceutical business to perhaps the biggest rising star in healthcare. The company's ...